ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 41 | October 25, 1985

Download PDF Visit The Full Archive

Related Articles

AAAS Urges Bush To Continue Funding For Stem Cell Research; ONS Hires Arent Fox.

March 9, 2001

Niass General’s Sanders Reported offered Asst. Secretary Job

February 18, 1977

Henry Kaplan Was One Of The Century’s Top Scientists, DeVita Says

March 23, 1984

NCI RFP Available.

February 18, 2000

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

NCI Cooperative Group Clinical Trials Approved

July 31, 2009